GlassScriptPrepare for your visit
Rachel Downes
Ophthalmology · Cleveland, OH · NPI 1962066605
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,030.51
in general payments reported to CMS, 2019-2025 · $3,139 in 2025
The $3,139 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Who reported paying
General payments only, top 6 by amount.
- Harrow Eye, LLC $3,003.94
- Bausch & Lomb Americas INC. $1,416.58
- Eyepoint US, INC. $1,251.17
- Alimera Sciences, INC. $140.98
- Astellas Pharma US INC $118.80
- Regeneron Pharmaceuticals, INC. $66.65
Drugs and devices associated with these payments
Triesence Stellaris Elite Eyp-1901 Yutiq Stellaris Eylea Hd Eylea Hydrus Microstent
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Rachel Downes listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11447994/rachel-downes